Inflammatory Breast Cancer: Clinical Challenges, Evolving Concepts and Novel Treatments (People’s Choice)
Thursday, December 7 • 3:10 p.m. – 5:00 p.m. • Hemisfair Ballroom 1-2

Presentation: Is Inflammatory Breast Cancer a Genomically Different Type of Breast Cancer?

Frederick Howard, MD
University of Chicago,
Chicago, Illinois

What is your presentation about?
My presentation reviews studies that have compared the mutational and gene expression profiles of inflammatory breast cancer (IBC) and non-inflammatory breast cancer, as well as insights into the biology of IBC learned from preclinical and clinical studies.

What makes this topic important in 2023?
Inflammatory breast cancer carries a particularly poor prognosis, and better understanding potential molecular drivers of inflammatory breast cancer might eventually lead to novel therapeutic strategies.